A logical approach to planning health care services in relation to need Dr Christopher A Birt University of Liverpool
|
|
- Calvin Lloyd
- 5 years ago
- Views:
Transcription
1 EUREGIO III A logical approach to planning health care services in relation to need Dr Christopher A Birt University of Liverpool
2 PURPOSE OF A HEALTH SERVICE To utilise resources allocated to the health sector in such a way as to raise, most effectively, the health status of the whole population, taking full account of its known health problems and particular health needs.
3 DEMOGRAPHIC CHARACTERISTICS OF POPULATION Knowing the population: Size and distribution Age structure / old people and children Social class distribution Ethnic mix Inequalities of wealth Gender balance
4 EXAMPLE: NAIRN AND EAST KILBRIDE Nairn: Retirement town, elderly population Low SMR from CVD and cancer Low fertility rate East Kilbride: New town, married couples and families High SMR from CVD and cancer High fertility rate
5 SO THE SERVICES REQUIRED ARE: Nairn needs home-based care of the elderly, treatment services for CVD and cancer and terminal care facilities East Kilbride needs excellent maternity and child care services, population prevention of CVD and cancer and accident & emergency services
6 MEDICAL CARE OVER A CENTURY 1900: Treatment for acute episodes of infectious diseases, Old public health: sanitation, clean water, removing overcrowding. 2010: Chronic diseases: primary prevention, secondary prevention, treatment of acute episodes, rehabilitation. New public health: addressing the major determinants of health.
7 THE MAIN CONDITIONS ARE KNOWN Main conditions in Europe Cardiovascular diseases Neuropsychiatric disorders Cancer Digestive diseases Respiratory diseases Diabetes mellitus Musculoskeletal diseases Sense organ disorders Other NCDs Total Disease burden (DALYs) 23% 20% 11% 5% 4% 1% 4% 4% 5% 77% Deaths 52% 3% 19% 4% 4% 1% 0% 0% 2% 85%
8 CVD causes more >50% of all deaths in Europe Cardiovascular mortality (up to 65 years) in the WHO European Region Last available data <= 300 <= 240 <= 180 <= No data SDR per and is a main contributor to the almost 20 year difference in life expectancy across Europe
9 International comparisons CHD death rates in 2004, men & women aged World Health Organization (2004)
10 200 SDR, ischaemic heart disease, 0-64 per Belgium Finland Hungary Italy Latvia Poland Slovakia Spain United Kingdom
11 IMPACT CHD POLICY MODEL Original Aims To explain falls in CHD mortality in recent decades in some countries and & rises in others Subsequent Aims To predict future trends in CVD mortality To compare policy options for reducing CVD NEJM 2007; 356: 2388.
12 Explaining the fall in coronary heart disease deaths in England & Wales ? ,230 fewer deaths in Unal, Critchley & Capewell Circulation (9) 1101
13 Explaining the fall in coronary heart disease deaths in England & Wales ,230 fewer deaths in 2000 Risk Factors worse +13% Obesity (increase) +3.5% Diabetes (increase) +4.8% Physical activity (less) +4.4% Risk Factors better -71% Smoking -41% Cholesterol -9% Population BP fall -9% Deprivation -3% Other factors -8% Treatments -42% AMI treatments -8% Secondary prevention -11% Heart failure -12% Angina:CABG & PTCA -4% Angina: Aspirin etc -5% Hypertension therapies -3% 1981 Unal, Critchley & Capewell 2000 Circulation (9) 1101
14 IMPACT model: CHD mortality RISE in Beijing In 1999: 1820 Extra deaths attributable to risk factor changes Cholesterol 77% Diabetes 19% BMI 4% Smoking 1% 370 Fewer deaths by treatments AMI treatments 41% Hypertension 24% Secondary prevention 11% Heart failure 10% Aspirin for Angina 10% 1984 Critchley, Capewell et al Circulation : Angina:CABG & PTCA 2%
15 IMPACT model: CHD mortality fall in Finland Risk Factors-71% Cholesterol - 53% Smoking - 11% Blood pressure - 7% 375 fewer deaths in 1997 Treatments-24% AMI treatments - 4% Secondary prevention - 8% Heart failure -2% Angina:CABG & PTCA -8% Angina: Aspirin etc -2% Other Factors -5% Laatikainen et al Am J Epid
16 INTERHEART Study nine potentially modifiable risk factors account for over 90% of the risk of an initial acute myocardial infarction Population attributable risk fractions Smok ing H ypertension Lipids (ApoB/A1 ratio) Abdom obesity Diabetes F ruit & Veg Alcohol Exercise Psychosocial Other Salim Yusuf et al. Effect of potentially Capewellmodifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study). Lancet Sept 2004
17 Changes in diet PS ratio predicted a 24% drop in CHD mortality Dietary PS Ratio (polyunsaturated : saturated fat ratio) & CHD mortality in Poland (1990 onwards) superimposed on fat ratio /CHD risk in Nurses' Health Study (NHS) Zatonski & Willett. BMJ
18 SDR, ischaemic heart disease, 0-64 per 10,000 Hungary Czech Republic PolandPoland Source: WHO/Europe, European HFA Database January 2009
19 Potential changes in CHD mortality in England & Wales between 2000 and 2010 IF risk factors a) continue recent trends b) additional reductions already achieved elsewhere Unal et al J Clin Epid Capewell
20 LEVELS OF HEALTH INTERVENTION Primary Prevention Secondary Prevention Tertiary Care Rehabilitation Long Term Care Terminal Care
21 CORONARY HEART DISEASE Primary prevention: avoidance of tobacco and saturated fat Secondary prevention: risk factors raised serum LDL cholesterol, blood pressure Treatment: for acute episodes (medication and surgery) Rehabilitation: after acute attacks and surgery; medication for tertiary prevention Long term care: not usually relevant Terminal care: needed for some cases of heart failure
22 CORONARY HEART DISEASE Primary prevention will consist of two components of health promotion: health education, e.g. to create a nutritionally informed population health protection, to provide healthy food choices available at cheap prices (e.g. by reform of the CAP)
23 THE PREVENTION PARADOX A large number of people at a small risk may give rise to more cases than a small number of people who are at a high risk
24 24
25 BUILDING HEALTHIER HEARTS: IRELAND S CARDIOVASCULAR HEALTH STRATEGY Launched 1999 and addresses: The common aspects of prevention Treatment Rehabilitation of patients with coronary heart disease Overall aims To detect those at high risk To reduce the risk factor profile in the general population To deal effectively with those who have clinical disease To ensure the best survival and quality of life outcome for those who recover from an acute attack
26 80 SDR, trachea/bronchus/lung cancer, 0-64 per , male Belgium Finland Hungary Italy Latvia Poland Slovakia Spain United Kingdom
27 30 SDR, trachea/bronchus/lung cancer, 0-64 per , female Belgium Finland Hungary Italy Latvia Poland Slovakia Spain United Kingdom
28 LUNG CANCER Primary prevention: avoidance of tobacco Secondary prevention: not relevant (screening criteria not satisfied) Treatment: surgery, radiotherapy, chemotherapy usually palliative Rehabilitation: after surgery and other treatments Long term care: not relevant Terminal care: a major component of treatment for this condition
29 INEQUALITIES WITHIN COUNTRIES Socio-economic determinants Distribution of risk factors Burden of disease Access to health services Coping capacity
30
31 Policy Levels for Improving Health
32 IRELAND: NEW NATIONAL HEALTH STRATEGY Guiding principles Equity People-centredness Quality Accountability Funding Goals Developing human Better health for everyone resources Fair access Organizational reform Responsive and appropriate Information care delivery High performance Six frameworks for change Strengthening primary care Reform of acute hospital system
33 HEALTH STRATEGY DEVELOPMENT IDENTIFY TOP 10 HEALTH CHALLENGES For each, identify ideal mix of: Primary prevention Secondary prevention Therapy Rehabilitation Long term care Terminal care Then plan services required for this mix
34 TOP 10 ARE LIKELY TO INCLUDE: CVD: population prevention, high risk prevention, treatment, rehabilitation Obesity and diabetes: prevention and lifetime care Cancer: prevention, treatment, terminal care Alcohol and drugs: prevention, treatment, rehabilitation Ageing population: osteoporosis, accidents, care in the community
35 CAPITAL INVESTMENT FOR HEALTH SERVICES IN EUROPE On basis of plan for services: What type of primary care centres are needed, for which services? What types of hospitals / treatment centres are required? Centralised or disseminated? Emergency separated from planned care? Hospitals for rare conditions and superspecialties? What other supporting capital investment is required? Primary prevention initiatives? Rehabilitation centres? Terminal care?
36 RC56 COMPREHENSIVE AND BALANCED Upstream approach Health promotion Disease prevention Spanning the continuum Health-oriented health services Determinants Risk factors Diseases Comprehensive approach: Population-level prevention programmes Targeting high risk individuals Improved quality and coverage of care Systematic reduction of inequalities
37 THANKS FOR YOUR ATTENTION! Any questions? Let`s discuss!
38 ADDRESSING PREVENTION & POLICY ISSUES How can we: Explain falls in CHD mortality? Integrate treatment trends and risk factor trends? Simultaneously consider vast amounts of data? Quantify benefits from treatments and risk factors? Build a model! BUILD A MODEL...!
Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke
«L Europe de la santé au service des patients» 13-14 October 2008 - Institut Pasteur Paris Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke Simona Giampaoli National Centre of
More informationSecondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION
Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION Dr Kornelia Kotseva National Heart & Lung Insitute Imperial College London, UK on behalf of all investigators participating
More informationSurveillance and Chronic Disease Policies and Interventions: WHO European Region. Dr Jill Farrington Coordinator, Noncommunicable Diseases
Surveillance and Chronic Disease Policies and Interventions: WHO European Region Dr Jill Farrington Coordinator, Noncommunicable Diseases Overview European NCD Strategy Risk factor surveillance in Europe
More informationPopulation models of health impact of combination polypharmacy
Population models of health impact of combination polypharmacy Global Summit on Combination Polypharmacy for CVD, 25 th September 2012 Dr Mark Huffman Northwestern University, Chicago Charity No: 1110067
More informationTHE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures
THE CVD CHALLENGE IN NORTHERN IRELAND Together we can save lives and reduce NHS pressures The challenge of CVD continues today. Around 225,000 people in Northern Ireland live with the burden of cardiovascular
More informationProfessor Norman Sharpe. Heart Foundation West Coast
Professor Norman Sharpe Heart Foundation West Coast Primary Care the Keystone to Heart Health Improvement Norman Sharpe June 2013 The heart health continuum and the keystone position The culprit disease
More informationModels of preventive care in clinical practice to achieve 25 by 25
Models of preventive care in clinical practice to achieve 25 by 25 Professor David A Wood Garfield Weston Professor of Cardiovascular Medicine International Centre for Circulatory Health Imperial College
More informationEconomically efficient approaches to address chronic disease in developing countries
Economically efficient approaches to address chronic disease in developing countries Thomas A. Gaziano MD MSc Division of Cardiovascular Medicine Brigham & Women s Hospital Harvard Medical School Center
More informationthe high CVD risk smoker
Smoking Cessation: population and patients A comprehensive approach to the smoker the high CVD risk smoker Catriona Jennings Cardiovascular Specialist Research Nurse Imperial College London European Society
More informationEstimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries
1 Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries Introduction Mariachiara Di Cesare and Mike Murphy Department of Social Policy, London
More informationUK bowel cancer care outcomes: A comparison with Europe
UK bowel cancer care outcomes: A comparison with Europe What is bowel cancer? Bowel cancer, which is also known as colorectal or colon cancer, is a cancer that affects either the colon or the rectum. The
More informationManuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal
Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Public Health Public health is the science and art of preventing disease, prolonging
More informationInequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe
Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe 21st Congress of the European Association of Dental Public Health 1 October 2016 Budapest
More informationThe challenge of obesity in the WHO European Region
Fact sheet EURO/13/05 Copenhagen, Bucharest, 12 September 2005 The challenge of obesity in the WHO European Region Obesity poses one of the greatest public health challenges for the 21st century, with
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:
More informationCardiovascular Disease the global virus
NCS 2013 Cardiovascular Disease the global virus Dr Justin Zaman BSc MBBS MRCP MSc PhD Consultant Cardiologist, James Paget University Hospital, Norfolk, UK Honorary Senior Lecturer, University of East
More informationDECLARATION OF CONFLICT OF INTEREST. None
DECLARATION OF CONFLICT OF INTEREST None Dietary changes and its influence on cardiovascular diseases in Asian and European countries Problems of Eastern European countries for cardiovascular disease prevention
More information2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE
2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE Massimo F Piepoli, MD, PhD, FESC, Piacenza, Italy on behalf of the 6 th Joint Task Force 2 3 Guidelines still based upon the principles of
More informationProof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government
Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease Produced on behalf of NHS Wales and Welsh Government April 2018 Table of Contents Introduction... 3 Variation in health services...
More informationGlycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men:
Glycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study Jaakko Mursu, Jyrki K. Virtanen, Tiina H. Rissanen,
More informationCoronary heart disease statistics edition. Steven Allender, Viv Peto, Peter Scarborough, Anna Boxer and Mike Rayner
Coronary heart disease statistics 2007 edition Steven Allender, Viv Peto, Peter Scarborough, Anna Boxer and Mike Rayner Health Promotion Research Group Department of Public Health, University of Oxford
More informationInternational model for prevention of chronic disease: Finland experience
International model for prevention of chronic disease: Finland experience Erkki Vartiainen, MD, Professor, Assistant Director General 06/12/2011 Erkki Vartiainen 1 2 Start of the North Karelia project
More informationThe cancer burden in the European Union and the European Region: the current situation and a way forward
The cancer burden in the European Union and the European Region: the current situation and a way forward Presented by Zsuzsanna Jakab WHO Regional Director for Europe Informal Meeting of Health Ministers
More informationPriorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region
Priorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region Zsuzsanna Jakab WHO Regional Director for Europe A big challenge Globally every year 7.6 million children die
More informationHealth System Financing Implications of Chronic Health Conditions: Insights from Sri Lanka
Health System Financing Implications of Chronic Health Conditions: Insights from Sri Lanka Prioritizing chronicity: An Agenda for Public Health Research on Chronic Disease for sub-saharan Africa and Asia
More information40% minimum reduction from
160 Circulatory Disease Mortality Target: Death rates in England 1993-2006 Persons under 75 Death / 100,000 population A fall of 44% over 10 years 140 120 100 80 60 40 20 141.0 84.2 Immortality guaranteed
More informationCoronary heart disease and stroke
4 Coronary heart disease and stroke Overview of cardiovascular disease Cardiovascular disease (CVD), also called circulatory disease, describes a group of diseases which are caused by blockage or rupture
More informationCombating NCDs Challenge and the Evolving Responses in India
Combating NCDs Challenge and the Evolving Responses in India Dr Sudhir Gupta Addl. Dy. Director General Ministry of Health & Family Welfare 2 nd November 2012 1 Contents of presentation NCDs as a public
More informationJUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012
SAMUEL TCHWENKO, MD, MPH Epidemiologist, Heart Disease & Stroke Prevention Branch Chronic Disease & Injury Section; Division of Public Health NC Department of Health & Human Services JUSTUS WARREN TASK
More informationWhat can the NHS do to reduce premature mortality? Professor Sir Mike Richards NHS Health Check National Learning Event April 2013
What can the NHS do to reduce premature mortality? Professor Sir Mike Richards NHS Health Check National Learning Event April 2013 The role of the NHS in reducing premature mortality Overview The scale
More informationGuidelines on cardiovascular risk assessment and management
European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine
More informationDisability, dementia and frailty in later life - mid-life approaches to prevention. Population based approaches to prevention
Section A: CPH to complete Name: Job titles: Address: Robin Ireland, Alexandra Holt & Simon Capewell* CEO & Researcher, Health Equalities Group; *Professor of Clinical Epidemiology Health Equalities Group,
More informationBridging health promotion intervention policy with behavioral risk factor surveillance in Thailand
Bridging health promotion intervention policy with behavioral risk factor surveillance in Thailand The 7 th World Alliance for Risk Factor Surveillance (WARFS) Global Conference Toronto, Ontario, Canada,
More informationEUROPEAN SURVEY OF CARDIOVASCULAR DISEASE PREVENTION AND DIABETES EUROASPIRE IV. GUY DE BACKER Ghent University,Belgium
EUROPEAN SURVEY OF CARDIOVASCULAR DISEASE PREVENTION AND DIABETES EUROASPIRE IV GUY DE BACKER Ghent University,Belgium ESC Congress 2012, aug.25-29th, Munich, Germany ESC Congress 2012, aug.25-29th, Munich,
More informationAlcohol-related harm in Europe and the WHO policy response
Alcohol-related harm in Europe and the WHO policy response Lars Moller Programme Manager World Health Organization Regional Office for Europe Date of presentation NCD global monitoring framework: alcohol-related
More informationEuropean Status report on Alcohol and Health
European Status report on Alcohol and Health Dr Lars Moller Regional Advisor a.i. WHO Regional Office for Europe Main killers in the WHO European Region Source: Preventing chronic diseases. A vital investment.
More informationMen & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013
Men & Health Promotion @ Work Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013 Difference can make a Difference Mens health: State of mens health Use of services Role of the
More informationPublic Health in Scotland. Association of Directors of Public Health 29 th November 2006
Public Health in Scotland Association of Directors of Public Health 29 th November 2006 Sir Henry Littlejohn and Sir William Gairdner Child Health in 19th century Glasgow Glasgow slums in 1870 Glasgow
More informationHeart Disease Genesis
Heart Disease Genesis The Ultimate Lecture on CAD origins Petr Polasek MD FRCPC FACC Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationFigure 1 Modelling of diseases in PRIMEtime (after Barendregt et al. [7])
PRIMEtime PRIMEtime is a new model that combines elements of the PRIME model [1], which estimates the effect of population-level changes in diet, physical activity, and alcohol and tobacco consumption
More informationThe Polypill for Secondary Prevention Is Entering the Cardiovascular Field: Worldwide Interest Based on Better Adherence and Economics
The Polypill for Secondary Prevention Is Entering the Cardiovascular Field: Worldwide Interest Based on Better Adherence and Economics Jose M. Castellano, MD, PhD Clinical Trials Coordinator, CNIC, Madrid,
More informationSocioeconomic Factors, Work and Chronic Diseases
Winnie, a -years old British women Socioeconomic Factors, Work and Chronic Diseases Jussi Vahtera Professor of Public Health University of Turku Finnish Institute of Occupational Health Finland Davey-Smith
More informationThe local healthcare system: Focusing on health
The local healthcare system: Focusing on health Sian Griffiths Professor of Public Health Director of the School of Public Health Chairman, Department of Community and Family Medicine The Chinese University
More informationLessons from the European Health Report: implications for sustainable societies Dr Claudia Stein MD, PhD, FFPH
Lessons from the European Health Report: implications for sustainable societies Dr Claudia Stein MD, PhD, FFPH Director Division of Information, Evidence, Research and Innovation WHO Regional Office for
More informationAlcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe
Alcohol in Europe and Brief Intervention Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe Global risk factors ranked by attributable burden of disease 2010 (GBD, Lancet,
More informationUnderage drinking in Europe
Underage drinking in Europe There are two major studies on underage drinking which are published every 4 years: HBSC (Health Behaviour in School-aged Children) and ESPAD (The European School survey Project
More informationThe burden caused by alcohol
The burden caused by alcohol Presentation at REDUCING THE HARM CAUSED BY ALCOHOL: A COORDINATED EUROPEAN RESPONSE Tuesday, November 13 Jürgen Rehm Centre for Addiction and Mental Health, Toronto, Canada
More informationCombatting noncommunicable diseases global burden and best practices
Combatting noncommunicable diseases global burden and best practices Renu Garg, MD, MPH Medical Officer Noncommunicable Diseases WHO Thailand Outline Global burden Strategies for NCD prevention and control
More informationRheumatoid Arthritis Disease Burden and Access to Treatment
Berlin, April 2012 Rheumatoid Arthritis Disease Burden and Access to Treatment Gisela Kobelt, PhD Visiting Professor, Lund University (Sweden) President, European Health Economics (France) Disclaimers
More informationIdentification of subjects at high risk for cardiovascular disease
Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Identification of subjects at high risk for cardiovascular disease Lars Rydén Karolinska Institutet
More informationHealth and well-being a perspective from WHO
Meeting of Chief Medical Officers and Chief Nursing Officers Health and well-being a perspective from WHO Zsuzsanna Jakab WHO Regional Director for Europe Health 2020 European policy framework Health 2020
More informationEuropean status report on alcohol and health Leadership, awareness and commitment
European status report on alcohol and health 2014 Leadership, awareness and commitment Leadership, awareness and commitment Background Strong leadership from national and local governments is essential
More informationHealth and. Consumers
www.openprogram.eu EU action on obesity Obesity Prevention through European Network Closing event Amsterdam 25 November 2016 Attila Balogh Health determinants and inequalities European Commission Directorate-General
More informationProf. Dr. Gabor Ternak
Prof. Dr. Gabor Ternak Noninfectious diseases can't be passed from one person to another. Instead, these types of diseases are caused by factors such as the environment, genetics and lifestyle. The term
More informationVascular checks a vascular risk assessment and management. Heather White Deputy Branch Head Vascular Programme
Vascular checks a vascular risk assessment and management Heather White Deputy Branch Head Vascular Programme Three Questions (1) What is the starting point? (2) Where are we now? (3) What happens next?
More informationCardiovascular Disease and Diabetes Policies for Better Health and Quality of Care
Policy Brief Cardiovascular Disease and Diabetes Policies for Better Health and Quality of Care June 2015 Directorate for Employment, Labour and Social Affairs Over the last few decades, mortality from
More informationThis work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.
The State of Cardiovascular Disease in the Kyrgyz Republic Ryskul B. Kydyralieva The National Center of Cardiology and Internal Medicine named after academician M.Mirrahimov at Ministry of Health of the
More informationExtrapolation and potential impact of IPHS deployment in Europe
SIMPHS2 Validation Workshop Brussels, 31 Jan 2012 1 SIMPHS2 Validation Workshop Extrapolation and potential impact of IPHS deployment in Europe JRC IPTS IS Unit Ioannis Maghiros, Fabienne Abadie, Maria
More informationASIA-PACIFIC HEART HEALTH CHARTER
ASIA-PACIFIC HEART HEALTH CHARTER The Asia-Pacific Heart Health Charter has been developed by the Asia-Pacific Heart Network in collaboration with Asia Pacific Society of Cardiology to help stem the growing
More informationCardiovascular Risk Assessment and Management Making a Difference
Cardiovascular Risk Assessment and Management Making a Difference Norman Sharpe March 2014 Numbers and age-standardised mortality rates from all causes, by sex, 1950 2010 Death rates halved Life expectancy
More informationCurrent Issues in Cardiovascular Risk Management. Les Toop Norman Sharpe June 2014
Current Issues in Cardiovascular Risk Management Les Toop Norman Sharpe June 2014 Risk assessment is just the beginning of a conversation Les Toop Department of General Practice, University of Otago, Christchurch
More informationProgress in improving cancer services and outcomes in England. Report. Department of Health, NHS England and Public Health England
Report by the Comptroller and Auditor General Department of Health, NHS England and Public Health England Progress in improving cancer services and outcomes in England HC 949 SESSION 2014-15 15 JANUARY
More informationResults of the North Karelia Project and national NCD prevention
Results of the North Karelia Project and national NCD prevention Erkki Vartiainen, MD, Professor, Assistant Director General 28/03/2011 Erkki Vartiainen 1 2 Start of the North Karelia project (1) Seven
More informationJohn J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam
Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention
More informationCoronary heart disease statistics edition
Coronary heart disease statistics 2010 edition Peter Scarborough, Prachi Bhatnagar, Kremlin Wickramasinghe, Kate Smolina, Colin Mitchell and Mike Rayner Health Promotion Research Group Department of Public
More informationNCDs and H2020. The Big Shift. Gauden Galea Paris, June 2012
NCDs and H2020 The Big Shift Gauden Galea Paris, June 2012 Health 2020 Inequity Governance Whole of society Public health capacity Address Inequity 80 Life expectancy at birth, in years Address the social
More informationDiabetes Mellitus: A Cardiovascular Disease
Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular
More information2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.
2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature
More informationHeart Outcomes Prevention Evaluation (HOPE) - 3 Combined Lipid Lowering and Blood Pressure Lowering in Moderate Risk People
November September 23, 20, 20102012 Heart Outcomes Prevention Evaluation (HOPE) - 3 Combined Lipid Lowering and Blood Pressure Lowering in Moderate Risk People Eva Lonn, Jackie Bosch, Jane Castelli, Andrea
More informationCurrent levels and recent trends in health inequalities in the EU: Updates from the EU Report
Current levels and recent trends in health inequalities in the EU: Updates from the EU Report Anne Scott London Health Observatory Expert Working Group on Social Determinants and Health Inequalities Luxembourg,
More informationBlood pressure monitoring and control by cardiovascular disease status in UK primary care: 10 year retrospective cohort study
Journal of Public Health Vol. 33, No. 2, pp. 302 309 doi:10.1093/pubmed/fdq078 Advance Access Publication 12 October 2010 Blood pressure monitoring and control by cardiovascular disease status in UK primary
More informationCaribbean Expert Consultation on Scaling Up Population-Based Screening and Management of CVD and Diabetes: Context and Objectives
Caribbean Expert Consultation on Scaling Up Population-Based Screening and Management of CVD and Diabetes: Context and Objectives T. Alafia Samuels MBBS, MPH, PhD: PAHO/WHO (Montego Bay, Jamaica, 4 March
More informationGlobal overview of Non- Communicable Diseases (NCDs)
Faculty of Medicine الصحة العامة (31505291) Health Public Lecture 15 Global overview of Non- Communicable Diseases (NCDs) By Hatim Jaber MD MPH JBCM PhD 25-7-2018 1 1. The global health impact of mental
More informationCardiac Rehabilitation after Primary Coronary Intervention CONTRA
DEBATE SESSION Is there a role for cardiac rehabilitation in the modern era of Percutaneous coronary intervention and coronary artery bypass grafting? Cardiac Rehabilitation after Primary Coronary Intervention
More informationTackling Health Inequalities in England
Congrès national des Observatoires régionaux de la santé 2008 - Les inégalités de santé Marseille, 16-17 octobre 2008 Tackling Health Inequalities in England Dr Bobbie Jacobson, Director London Health
More informationTable 7.1 Summary information for lung cancer in Ireland,
7 Lung cancer 7.1 Summary Lung cancer is the third most common cancer in Ireland, accounting for 15% of cancers in men and 9% in women, if non-melanoma skin cancer is excluded (table 7.1). Each year, approximately
More informationDianne Johnson / Lee Panter / Sarah McNulty
Cardiovascular Disease (heart disease and stroke) READER INFORMATION Need Identified Lead Author Cardiovascular Disease Dianne Johnson / Lee Panter / Sarah McNulty Date completed 07/02/11 Director approved
More informationNew indicators to be added to the NICE menu for the QOF and amendments to existing indicators
New indicators to be added to the for the QOF and amendments to existing indicators 1 st September 2015 Version 1.1 This document was originally published on 3 rd August 2015, it has since been updated.
More informationHealth and Global Policy Institute Breakfast Briefing 29 November 2011
Health and Global Policy Institute Breakfast Briefing 29 November 2011 Judith Watt Strategic t Consultant t to NCD Alliance www.ncdalliance.org Good morning... I will address three points Why tackling
More informationFRUIT AND VEGETABLES CONSUMPTION AND PREVENTION OF CHRONIC DIET-RELATED NON- COMMUNICABLE DISEASES. Mike Rayner Chair EHN Expert Group on Nutrition
British Heart Foundation Health Promotion Research Group FRUIT AND VEGETABLES CONSUMPTION AND PREVENTION OF CHRONIC DIET-RELATED NON- COMMUNICABLE DISEASES Mike Rayner Chair EHN Expert Group on Nutrition
More informationConsidering depression as a risk marker for incident coronary disease
Considering depression as a risk marker for incident coronary disease Dr Adrienne O'Neil Senior Research Fellow Melbourne School of Population & Global Health The University of Melbourne & Visiting Fellow
More informationMonthly measles and rubella monitoring report
SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data
More informationThe health economic landscape of cancer in Europe
1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor
More informationAndrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University
CARDIOVASCULAR RISK FACTORS ORIGINAL ARTICLE Do We Correctly Assess the Risk of Cardiovascular Disease? Characteristics of Risk Factors for Cardiovascular Disease Depending on the Sex and Age of Patients
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Peripheral arterial disease Potential output:
More informationLincolnshire JSNA: Cancer
What do we know? Summary Around one in three of us will develop cancer at some time in our lives according to our lifetime risk estimation (Sasieni PD, et al 2011). The 'lifetime risk of cancer' is an
More informationSecond presentation: Ms Leanne Riley Team Leader Surveillance and Population-based Prevention Department of Chronic Diseases and Health Promotion
Second presentation: Ms Leanne Riley Team Leader Surveillance and Population-based Prevention Department of Chronic Diseases and Health Promotion World Health Organization Targets presented in the first
More informationResponding To The Global Challenge of NCDs
Responding To The Global Challenge of NCDs Prof K Srinath Reddy President, Public Health Foundation of India Bernard Lown Professor of Cardiovascular Health, Harvard School of Public Health Projected
More informationThe Risk of Alcohol in Europe. Bridging the Gap June 2004
The Risk of Alcohol in Europe Bridging the Gap 16-19 June 2004 1. What is the relationship between alcohol and the risk of heart disease? 2. What is the relationship between alcohol and the risk of other
More informationTable 6.1 Summary information for colorectal cancer in Ireland,
6 Colorectal cancer 6.1 Summary Colorectal cancer is the second most common cancer in Ireland (excluding non-melanoma skin cancer). It accounts for 12% of all malignant neoplasia in females and 15% in
More information5. Cardiovascular Disease & Stroke
5. Cardiovascular Disease & Stroke 64: Self-Reported Heart Disease 66: Heart Disease Management 68: Heart Disease Mortality 70: Heart Disease Mortality Across Life Span 72: Stroke Mortality 185: Map 3:
More informationEuropean Association of Dental Public Health Prevention of Oral Cancer
European Association of Dental Public Health Prevention of Oral Cancer Special Interest Working Group Thursday 14th November 2013 PD Dr. Katrin Hertrampf, MPH Dr. Colwyn Jones, Associate Editor Malta 2013
More information14. HEALTHY EATING INTRODUCTION
14. HEALTHY EATING INTRODUCTION A well-balanced diet is important for good health and involves consuming a wide range of foods, including fruit and vegetables, starchy whole grains, dairy products and
More informationStroke secondary prevention. Gill Cluckie Stroke Nurse Consultant St. George s Hospital
Stroke secondary prevention Gill Cluckie Stroke Nurse Consultant St. George s Hospital Stroke recurrence The risk of recurrent stroke is greatest after first stroke 2 3% of survivors of a first stroke
More informationPrevention in Europe
Prevention in Europe Geneviève Derumeaux Créteil University, France Ian M Graham Trinity College, Dublin ESC: 2016 Lipid guidelines 2016 Joint Prevention Guidelines Cardiovascular disease in Europe Nick
More informationGlobal Differences in Atherosclerosis
2 8 Global Differences in Atherosclerosis Philip A. Poole-Wilson Size of the Problem.............................. 653 Changing Pattern of Disease Around the World...... 654 Country Differences in Atherosclerosis.............
More informationInequalities in CVD risk factors
Inequalities in CVD risk factors Causes, Consequences & Challenges Simon Capewell Professor of Clinical Epidemiology LIVERPOOL UNIVERSITY UK May 7 th 2013 Thanks: Julia Critchley, Martin O Flaherty, Peter
More informationOverview of drug-induced deaths in Europe - What does the data tell us?
Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug
More informationBetter Health for All in Latvia
Better Health for All in Latvia The health strategy for the European Region (Health 2020) and the Latvian Public Health Strategy 2011 2017 Zsuzsanna Jakab WHO Regional Director for Europe 18 April 2011,
More information